東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Human Immunodeficiency Virus-1 Infec...

Sugawara, Sho.

Linked to FindBook

Google Book

Amazon

博客來

Human Immunodeficiency Virus-1 Infection and Type 1 Interferon Responses.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Human Immunodeficiency Virus-1 Infection and Type 1 Interferon Responses./
Author:	Sugawara, Sho.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
Description:	96 p.
Notes:	Source: Dissertations Abstracts International, Volume: 81-10, Section: B.
Contained By:	Dissertations Abstracts International81-10B.
Subject:	Virology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27805494
ISBN:	9781392643297

Human Immunodeficiency Virus-1 Infection and Type 1 Interferon Responses.
Sugawara, Sho.

Human Immunodeficiency Virus-1 Infection and Type 1 Interferon Responses. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 96 p.

Source: Dissertations Abstracts International, Volume: 81-10, Section: B.

Thesis (Ph.D.)--The Johns Hopkins University, 2019.

This item must not be sold to any third party vendors.

HIV-1 infects 37 million people worldwide. Despite the success of antiretroviral therapy (ART), there are still several adverse health outcomes in people living with HIV-1 (PLWH). In addition, most PLWH face lifelong therapy as there is no cure. Type 1 interferons (IFN) are broadly-acting cytokines that promote endogenous antiviral activities. Exogenous type 1 IFN-based therapy can control several viral infections, but its efficacy on HIV-1 is limited. Thus, we hypothesized that antiviral responses to exogenous type 1 IFN are dampened during HIV-1 infection. We confirmed the dampened response to exogenous type 1 IFN in total CD4+ T cells from PLWH with uncontrolled viremia (HIV-UC) compared to healthy controls (HC). Surprisingly, type 1 IFN responses in PLWH with ART (HIV-ART) were not fully restored even after a year of virologic suppression. The dampened type 1 IFN response was associated with upregulation of type 1 IFN regulatory genes, particularly USP18. We confirmed the finding in a separate cohort of HIV-1/HCV co-infected persons who were administered pegylated type 1 IFN (PEG-IFN): baseline expression of USP18 was strongly and inversely associated with the induction of antiviral interferon-stimulated genes (ISGs). Moreover, baseline USP18 levels were inversely associated with the subsequent plasma HIV-1 RNA decline. We also demonstrated that the diminished type 1 IFN response can be transferred to HIV-1 uninfected target cells by soluble mediators, particularly by type 1 IFN from HIV-1 infected cells, and knockdown of USP18 can restore the diminished response. Targeting USP18 may represent an alternative approach to improve type 1 IFN responses in PLWH.

ISBN: 9781392643297Subjects--Topical Terms:

642304
Virology.
Subjects--Index Terms:

HIV-1 infection

Human Immunodeficiency Virus-1 Infection and Type 1 Interferon Responses.
LDR:02755nmm a2200325 4500 001 2273098
005 20201105110341.5
008 220629s2019 ||||||||||||||||| ||eng d
020 $a 9781392643297
035 $a (MiAaPQ)AAI27805494
035 $a (MiAaPQ)0098vireo5073Sugawara
035 $a AAI27805494
040 $a MiAaPQ $c MiAaPQ
100 1 $a Sugawara, Sho. $3 3550529
245 1 0 $a Human Immunodeficiency Virus-1 Infection and Type 1 Interferon Responses.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 96 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-10, Section: B.
500 $a Advisor: Clements, Janice E.
502 $a Thesis (Ph.D.)--The Johns Hopkins University, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a HIV-1 infects 37 million people worldwide. Despite the success of antiretroviral therapy (ART), there are still several adverse health outcomes in people living with HIV-1 (PLWH). In addition, most PLWH face lifelong therapy as there is no cure. Type 1 interferons (IFN) are broadly-acting cytokines that promote endogenous antiviral activities. Exogenous type 1 IFN-based therapy can control several viral infections, but its efficacy on HIV-1 is limited. Thus, we hypothesized that antiviral responses to exogenous type 1 IFN are dampened during HIV-1 infection. We confirmed the dampened response to exogenous type 1 IFN in total CD4+ T cells from PLWH with uncontrolled viremia (HIV-UC) compared to healthy controls (HC). Surprisingly, type 1 IFN responses in PLWH with ART (HIV-ART) were not fully restored even after a year of virologic suppression. The dampened type 1 IFN response was associated with upregulation of type 1 IFN regulatory genes, particularly USP18. We confirmed the finding in a separate cohort of HIV-1/HCV co-infected persons who were administered pegylated type 1 IFN (PEG-IFN): baseline expression of USP18 was strongly and inversely associated with the induction of antiviral interferon-stimulated genes (ISGs). Moreover, baseline USP18 levels were inversely associated with the subsequent plasma HIV-1 RNA decline. We also demonstrated that the diminished type 1 IFN response can be transferred to HIV-1 uninfected target cells by soluble mediators, particularly by type 1 IFN from HIV-1 infected cells, and knockdown of USP18 can restore the diminished response. Targeting USP18 may represent an alternative approach to improve type 1 IFN responses in PLWH.
590 $a School code: 0098.
650 4 $a Virology. $3 642304
653 $a HIV-1 infection
653 $a type 1 IFN
690 $a 0720
710 2 $a The Johns Hopkins University. $b Molecular Biology and Genetics. $3 3434285
773 0 $t Dissertations Abstracts International $g 81-10B.
790 $a 0098
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27805494